Premium
Compartmentalization regulates the interaction between the platelet integrin α IIb β 3 and ICln
Author(s) -
Larkin Deirdre,
Treumann Achim,
Murphy Derek,
DeChaumont Ciaran,
Kiernan Aoife,
Moran Niamh
Publication year - 2009
Publication title -
british journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.907
H-Index - 186
eISSN - 1365-2141
pISSN - 0007-1048
DOI - 10.1111/j.1365-2141.2008.07483.x
Subject(s) - integrin , chemistry , microbiology and biotechnology , platelet , platelet activation , abciximab , biophysics , biochemistry , cell , immunology , biology , psychology , psychiatry , myocardial infarction , conventional pci
Summary The volume‐regulating protein, ICln, interacts with the conserved KxGFFKR α‐integrin signature motif. ICln is an abundant protein (4455 ± 650 molecules/platelet) found exclusively in the soluble cytosolic fraction of unactivated platelets. In contrast, its binding partner, the platelet integrin α IIb β 3 , is present in detergent‐insoluble fractions associated with membrane and cytoskeleton subcellular localizations. This study investigated factors that regulate the interaction of ICln with α IIb β 3 during platelet activation. His‐tagged recombinant ICln bound equally to purified α IIb β 3 and to integrin from resting or activated platelets. Binding was not affected by direct integrin activation with Mn ++ or by inhibitors of integrin occupancy (abciximab, RGD). However, the capacity for interaction between integrin and recombinant ICln was slowly downregulated following prolonged platelet activation for >300 s. In parallel, ICln redistributed to membrane and cytoskeletal platelet subcellular fractions. The time‐course of this redistribution preceded the downregulation of integrin binding capacity and suggests that only a short window of opportunity exists for ICln interaction with α IIb β 3 to occur. Thus, although ICln has the inherent capacity to bind to α IIb β 3 regardless of its activation state, it can only do so following platelet activation. Activation‐dependent subcellular redistribution of ICln represents a novel, temporally‐regulated mechanism for control of integrin function in platelets.